Bosun Asset Management’s Pfizer PFE Stock Holding History

Bosun Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,878	Closed	-$106K	–	161
2023 Q2	$106K	Buy	+2,878	New	+$112K	0.1%	127

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bosun Asset Management's PFE Position: Q3 2023 in Review

Bosun Asset Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 2,878 shares — an estimated $106K sold.

Bosun Asset Management first reported a position in PFE in Q2 2023 and held it in 1 quarter. The position peaked at $106K in Q2 2023. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Bosun Asset Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Bosun Asset Management sold 2,878 Pfizer shares in Q3 2023, an estimated $106K.
Bosun Asset Management first reported a position in Pfizer in Q2 2023 and held it in 1 quarter.
Bosun Asset Management's Pfizer position peaked at $106K in Q2 2023.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Bosun Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.